IIROC Trade Halt - Avagenesis Corp.
Vancouver, British Columbia--(Newsfile Corp. - December 30, 2016) - The following issues have been halted by IIROC: Company:
2016-12-30 4:08 PM EST
Avagenesis Corp. Receives ISO 13485 and 9001 for Bioprocessing and Cell Isolation System
Calgary, Alberta--(Newsfile Corp. - September 3, 2015) - Avagenesis Corp. (TSXV: VVA) ("Avagenesis" or the "Company") is pleased to announce that its licensed bioprocessing and cell isolation system has received a Certificate of Registration for compliance with ISO 13485 and 9001 (the "ISO Certification"). ISO Certification demonstrates to customers that the Company's contracted commercially manufactured bioprocessing system to isolate stem cells and regenerative cells from adipose...
2015-09-03 2:54 PM EDT
Avagenesis Corp. Completes Acquisition of Curastem Biomedical Corp.
Calgary, Alberta--(Newsfile Corp. - March 18, 2015) - Further to its news releases of January 15, 2015, and March 13, 2015, Avagenesis Corp. (TSXV: VVA) ("Avagenesis" or the "Company") today announced the closing of the transactions contemplated in the share exchange agreement dated as of January 15, 2015 between Avagenesis and Curastem Biomedical Corp., including the closing of a private placement by Curastem for gross proceeds of $696,992. The acquisition is subject to final approval by the...
2015-03-18 2:13 AM EDT
Avagenesis Corp. Receives TSXV Conditional Approval to the Acquisition of Curastem Biomedical Corp.
Calgary, Alberta--(Newsfile Corp. - March 13, 2015) - Further to its news release dated January 15, 2015, Avagenesis Corp. (TSXV: VVA) (“Avagenesis” or the “Company”) has received conditional approval from the TSX Venture Exchange (“TSXV”) of the proposed share exchange transaction with Curastem Biomedical Corp. (“Curastem”). The share exchange transaction is expected to close on Monday, March 16, 2015, pursuant to which the Company will issue 1,580,821 common shares as consideration for the...
2015-03-13 3:06 PM EDT
Avagenesis Corp. Appoints IR Consultant
Calgary, Alberta--(Newsfile Corp. - February 3, 2015) - Avagenesis Corp. (TSXV: VVA) ("Avagenesis" or the "Company"), is pleased to announce that it has retained the California-based firm of San Diego Torrey Hills Capital, Inc. ("Torrey") to conduct investor relations activities on behalf of the Company. Headed by Mr. Clifford Mastricola, Torrey is an investor and financial public relations firm specializing in introducing small-cap companies to broader institutional and retail investor...
2015-02-03 11:51 AM EST